Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate

J. B. Nelson, S. P. Hedican, D. J. George, A Hari Reddi, S. Piantadosi, M. A. Eisenberger, J. W. Simons

Research output: Contribution to journalArticle

532 Citations (Scopus)

Abstract

Prostate cancer is the second most common cause of death from cancer in U.S. men, and advanced, hormone-refractory disease is characterized by painful osteoblastic bone metastases. Endothelin-1, more commonly known as a potent vasoconstrictor, is a normal ejaculate protein that also stimulates osteoblasts. We show here that plasma immunoreactive endothelin concentrations are significantly elevated in men with metastatic prostate cancer and that every human prostate cancer cell line tested produces endothelin-1 messenger RNA and secretes immunoreactive endothelin. Exogenous endothelin-1 is a prostate cancer mitogen in vitro and increases alkaline phosphatase activity in new bone formation, indicating that ectopic endothelin-1 may be a mediator of the osteoblastic response of bone to metastatic prostate cancer.

Original languageEnglish (US)
Pages (from-to)944-949
Number of pages6
JournalNature Medicine
Volume1
Issue number9
StatePublished - 1995
Externally publishedYes

Fingerprint

Endothelin-1
Prostate
Prostatic Neoplasms
Adenocarcinoma
Bone
Endothelins
Osteoblasts
Vasoconstrictor Agents
Bone and Bones
Mitogens
Refractory materials
Alkaline Phosphatase
Osteogenesis
Cells
Hormones
Cause of Death
Plasmas
Messenger RNA
Neoplasm Metastasis
Cell Line

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995). Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Medicine, 1(9), 944-949.

Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. / Nelson, J. B.; Hedican, S. P.; George, D. J.; Reddi, A Hari; Piantadosi, S.; Eisenberger, M. A.; Simons, J. W.

In: Nature Medicine, Vol. 1, No. 9, 1995, p. 944-949.

Research output: Contribution to journalArticle

Nelson, JB, Hedican, SP, George, DJ, Reddi, AH, Piantadosi, S, Eisenberger, MA & Simons, JW 1995, 'Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate', Nature Medicine, vol. 1, no. 9, pp. 944-949.
Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Medicine. 1995;1(9):944-949.
Nelson, J. B. ; Hedican, S. P. ; George, D. J. ; Reddi, A Hari ; Piantadosi, S. ; Eisenberger, M. A. ; Simons, J. W. / Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. In: Nature Medicine. 1995 ; Vol. 1, No. 9. pp. 944-949.
@article{79ab3f537ed14ac1b16ae0940356917c,
title = "Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate",
abstract = "Prostate cancer is the second most common cause of death from cancer in U.S. men, and advanced, hormone-refractory disease is characterized by painful osteoblastic bone metastases. Endothelin-1, more commonly known as a potent vasoconstrictor, is a normal ejaculate protein that also stimulates osteoblasts. We show here that plasma immunoreactive endothelin concentrations are significantly elevated in men with metastatic prostate cancer and that every human prostate cancer cell line tested produces endothelin-1 messenger RNA and secretes immunoreactive endothelin. Exogenous endothelin-1 is a prostate cancer mitogen in vitro and increases alkaline phosphatase activity in new bone formation, indicating that ectopic endothelin-1 may be a mediator of the osteoblastic response of bone to metastatic prostate cancer.",
author = "Nelson, {J. B.} and Hedican, {S. P.} and George, {D. J.} and Reddi, {A Hari} and S. Piantadosi and Eisenberger, {M. A.} and Simons, {J. W.}",
year = "1995",
language = "English (US)",
volume = "1",
pages = "944--949",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate

AU - Nelson, J. B.

AU - Hedican, S. P.

AU - George, D. J.

AU - Reddi, A Hari

AU - Piantadosi, S.

AU - Eisenberger, M. A.

AU - Simons, J. W.

PY - 1995

Y1 - 1995

N2 - Prostate cancer is the second most common cause of death from cancer in U.S. men, and advanced, hormone-refractory disease is characterized by painful osteoblastic bone metastases. Endothelin-1, more commonly known as a potent vasoconstrictor, is a normal ejaculate protein that also stimulates osteoblasts. We show here that plasma immunoreactive endothelin concentrations are significantly elevated in men with metastatic prostate cancer and that every human prostate cancer cell line tested produces endothelin-1 messenger RNA and secretes immunoreactive endothelin. Exogenous endothelin-1 is a prostate cancer mitogen in vitro and increases alkaline phosphatase activity in new bone formation, indicating that ectopic endothelin-1 may be a mediator of the osteoblastic response of bone to metastatic prostate cancer.

AB - Prostate cancer is the second most common cause of death from cancer in U.S. men, and advanced, hormone-refractory disease is characterized by painful osteoblastic bone metastases. Endothelin-1, more commonly known as a potent vasoconstrictor, is a normal ejaculate protein that also stimulates osteoblasts. We show here that plasma immunoreactive endothelin concentrations are significantly elevated in men with metastatic prostate cancer and that every human prostate cancer cell line tested produces endothelin-1 messenger RNA and secretes immunoreactive endothelin. Exogenous endothelin-1 is a prostate cancer mitogen in vitro and increases alkaline phosphatase activity in new bone formation, indicating that ectopic endothelin-1 may be a mediator of the osteoblastic response of bone to metastatic prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0029085123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029085123&partnerID=8YFLogxK

M3 - Article

C2 - 7585222

AN - SCOPUS:0029085123

VL - 1

SP - 944

EP - 949

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -